On November 30, 2016, the fourth participant was enrolled at the recently initiated Boulder, Colorado study site in our ongoing Phase 1 study of the psychological effects of MDMA when used in a therapeutic setting by healthy volunteers. Marcela Ot’alora, M.A., L.P.C., is serving as Principal Investigator of the Boulder site. Enrollment in this study is limited by invitation only to therapists in training to work on MAPS-sponsored clinical trials of MDMA-assisted psychotherapy for PTSD. This study has currently enrolled 19 out of 100 participants across the study sites in Boulder, Colorado, and Charleston, South Carolina. Learn more…
